Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| PharmaEssentia 6446.TW | Pharmaceuticals: Major | $15.0B | 0% | +67% | +78% | 40% | 31.9× |
| Lin BioScience 6696.TWO | Biotechnology | $3.98B | -2% | +305% | n/a | n/a | n/a |
| Caliway Biopharmaceuticals 6919.TW | Biotechnology | $3.32B | -6% | -25% | -54% | -6,983% | n/a |
| PELL Bio-Med Technology 6949.TW | Biotechnology | $1.62B | +16% | +28% | +8% | -1,463% | n/a |
| TLC BioSciences 7924.TWO | Biotechnology | $1.50B | -7% | n/a | n/a | n/a | n/a |
| Bora Pharmaceuticals 6472.TW | Pharmaceuticals: Other | $1.25B | -19% | -2% | +7% | 14% | 10.8× |
| Lotus Pharmaceutical 1795.TW | Pharmaceuticals: Major | $921M | -33% | -37% | +67% | 21% | 9.8× |
| Steminent Biotherapeutics 7729.TWO | Biotechnology | $668M | +50% | +292% | n/a | n/a | n/a |
| Center Laboratories 4123.TWO | Pharmaceuticals: Major | $639M | -13% | -29% | +14% | 9% | n/a |
| SunMax Biotechnology 4728.TWO | Medical Specialties | $630M | -3% | 0% | +19% | 51% | n/a |
| TTY Biopharm 4105.TWO | Pharmaceuticals: Major | $615M | -1% | +10% | +5% | 29% | 10.2× |
| Oneness Biotech 4743.TWO | Pharmaceuticals: Major | $580M | -12% | -13% | +19% | -589% | n/a |
| CHO Pharma 6586.TWO | Biotechnology | $488M | -25% | +24% | -47% | -17,694% | n/a |
| TaiMed Biologics 4147.TWO | Biotechnology | $480M | -1% | +19% | +7% | -31% | n/a |
| YungShin Global 3705.TW | Pharmaceuticals: Major | $472M | -5% | +5% | -5% | 15% | n/a |
| Handa Pharmaceuticals 6620.TWO | Pharmaceuticals: Major | $469M | -29% | +45% | -16% | 30% | 24.9× |
| HanchorBio 7827.TW | Biotechnology | $462M | -27% | n/a | n/a | -4,673% | 2.3× |
| EirGenix 6589.TW | Biotechnology | $444M | +1% | +15% | +58% | -51% | n/a |
| Scinopharm Taiwan 1789.TW | Biotechnology | $435M | -5% | -2% | -5% | -4% | 39.4× |
| Ever Supreme Bio Technology 6712.TWO | Biotechnology | $427M | -10% | +11% | +13% | 47% | 26.2× |
| Medigen Vaccine Biologics 6547.TWO | Biotechnology | $424M | -16% | -8% | +44% | -5% | 170.0× |
| Synmosa Biopharma 4114.TWO | Pharmaceuticals: Major | $423M | -13% | -1% | +21% | 10% | n/a |
| Gongwin Biopharm 6617.TWO | Medical Distributors | $412M | -8% | +87% | +12% | -530% | n/a |
| Elixiron Immunotherapeutics (Cayman) 7871.TWO | Pharmaceuticals: Major | $412M | -17% | +64% | +6,162% | -194% | n/a |
| Lumosa Therapeutics 6535.TWO | Pharmaceuticals: Major | $406M | +10% | -37% | -25% | -803% | n/a |
| Excelsior Medical 4104.TW | Medical Distributors | $404M | -4% | +5% | +11% | 8% | n/a |
| Taidoc Technology 4736.TW | Medical Specialties | $387M | -7% | 0% | 0% | 19% | n/a |
| ACRO Biomedical 6748.TWO | Medical Specialties | $377M | -8% | +158% | +45% | -178% | n/a |
| 6467 6467.TW | Pharmaceuticals: Major | $368M | n/a | n/a | n/a | -2,618% | n/a |
| Daiken Biomedical 7780.TW | Pharmaceuticals: Other | $342M | -10% | -19% | n/a | 18% | n/a |
| Grape King Bio 1707.TW | Pharmaceuticals: Other | $342M | -10% | -27% | -5% | 19% | 9.7× |
| Standard Chemical & Pharmaceutical 1720.TW | Pharmaceuticals: Major | $329M | -4% | -1% | +5% | 22% | n/a |
| Foresee Pharmaceuticals 6576.TWO | Pharmaceuticals: Major | $322M | -10% | -12% | +6% | -104% | n/a |
| AP Biosciences 6945.TWO | Biotechnology | $321M | -2% | -31% | n/a | n/a | n/a |
| TCI 8436.TWO | Pharmaceuticals: Other | $312M | -12% | -24% | -4% | 18% | 9.9× |
| Universal Vision Biotechnology 3218.TWO | Medical/Nursing Services | $309M | -8% | -4% | +5% | 31% | 9.2× |
| OBI Pharma 4174.TWO | Pharmaceuticals: Major | $295M | +29% | +135% | -2% | -2,968% | n/a |